Sign In
Buy NSRGY
$99.23
-1.28 (-1.27%)
At Close: Aug 10, 2026
Seres to sell bacterial infection drug to Nestle Health for an undisclosed sum
07:03am, Thursday, 06'th Jun 2024
Seres Therapeutics said on Thursday it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of its bacterial infection drug and related intellectual prop
Nestle CEO: saw pressure among consumers in the first quarter
04:00am, Monday, 03'rd Jun 2024
Nestle CEO Mark Schneider sat down exclusively with CNBC's Silvia Amaro, telling her the company saw pressure among consumers through the first quarter.
Nutritional needs for users of GLP-1 drugs are 'shifting', Nestle CEO says
11:35am, Thursday, 30'th May 2024
Nestle CEO Mark Schneider discusses the impact of GLP-1 drugs on the food industry and the company's products that are tailored to users of the drugs.
Nestle's CEO is 'very closely' following the ultra-processed food debate
06:30am, Thursday, 30'th May 2024
CNBC's Silvia Amaro sits down with Nestle CEO Mark Schneider for an exclusive conversation spanning food products, coffee and cocoa prices and the rise of GLP-1 drugs.
Nutritional needs are 'shifting' amid rise of weight loss drugs, says Nestle CEO
01:19am, Thursday, 30'th May 2024
The rise of weight loss drugs means consumers' nutritional needs are "shifting," Nestle CEO Mark Schneider told CNBC's Silvia Amaro. Nestle is looking to capitalize on the popularity of the GLP-1 drug
KRYAY or NSRGY: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 28'th May 2024
Investors interested in Food - Miscellaneous stocks are likely familiar with Kerry Group PLC (KRYAY) and Nestle SA (NSRGY). But which of these two stocks offers value investors a better bang for their
Sip on Profits: 3 Top Coffee Stocks to Perk Up Your Returns
06:41am, Tuesday, 28'th May 2024
Imagine if, for every cup of coffee you bought, you instead invested that money into coffee stocks. I am not suggesting you stop drinking coffee.
Plunge Protection: 3 Stocks to Hold When the Market Dives
06:15am, Monday, 27'th May 2024
The stock market is at record highs, but the next bear market could be right around the corner. Investors shouldn't become complacent and should be looking for the best defensive stocks to buy.
Nestle Enters the Weight Loss Game With Food for Ozempic Users. What to Know.
10:28am, Wednesday, 22'nd May 2024
Nestle (OTCMKTS: NSRGY ) is getting into the weight loss business with new packs of frozen food designed for Ozempic users and others trying to slim down. Nestle is offering these frozen foods for wei
Nestlé launches food line targeting Ozempic, other weight-loss drug users
09:32pm, Tuesday, 21'st May 2024
Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years.
Ozempic users will soon get their own heat-and-eat meals
11:53am, Tuesday, 21'st May 2024
A new line of frozen foods will cater to users of weight loss drugs like Ozempic and Wegovy. Nestlé's Vital Pursuit brand will include sandwiches and bowls.
Nestle launches new range to tap into Wegovy surge
11:03am, Tuesday, 21'st May 2024
Nestle is to launch a new range of cheap frozen pizzas and pasta in the US to tap into the burgeoning market for users of weight loss drugs such as Wegovy and Ozempic. The new products, which will se
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
07:41am, Tuesday, 21'st May 2024
Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Nestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users
07:04am, Tuesday, 21'st May 2024
Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as Wegovy or Ozempic for weight
Dr Reddy's Laboratories' CEO says Nestle has an 'amazing portfolio'
04:34am, Wednesday, 08'th May 2024
Erez Israeli, CEO of Dr Reddy's Laboratories, discusses its joint venture with Nestle India.
